Prognostic factors in cancer of unknown primary site

被引:15
|
作者
Jose Fernandez-Cotarelo, Maria [1 ]
Manuel Guerra-Vales, Juan [2 ]
Colina, Francisco [3 ]
de la Cruz, Javier [4 ]
机构
[1] Hosp Mostoles, Dept Internal Med, Madrid 28935, Spain
[2] Univ Hosp 12 Octubre, CIBERESP, Dept Internal Med, Madrid, Spain
[3] Univ Hosp 12 Octubre, CIBERESP, Dept Pathol, Madrid, Spain
[4] Univ Hosp 12 Octubre, CIBERESP, Clin Epidemiol Unit, Madrid, Spain
来源
TUMORI JOURNAL | 2010年 / 96卷 / 01期
关键词
tumor metastasis; unknown primary tumors; survival; prognosis; SERUM-ALBUMIN LEVELS; PRIMARY-CARCINOMA; LIVER METASTASIS; PRIMARY ORIGIN; PRIMARY TUMORS; SURVIVAL; MANAGEMENT; MARKERS; MODEL; EXPERIENCE;
D O I
10.1177/030089161009600118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aims and background. Patients with cancer of an unknown primary site (CUP) usually have a poor outcome. The identification of prognostic factors that affect survival can help clinicians find a better approach to such cases in terms of diagnostic and therapeutic management. Methods. We conducted a retrospective study including the cases of CUP recorded at the University Hospital 12 de Octubre Tumor Registry between 1999 and 2003. Results. CUP was diagnosed in 265 patients during the analyzed period. One hundred and seventy-one were men (64.5%) and the mean age of the patients was 66.9 years (range 32-98 years). The median survival was 2.5 months, and the survival rate was 35.1% 6 months from diagnosis (95% CI: 28.9-41.3) and 24.5% 1 year from diagnosis (95% CI:.18.7-30.3). Univariate analysis revealed as significant predictive variables of a better outcome age under 70 years; involvement of a single organ; normal serum levels of alkaline phosphatase and albumin; normal erythrocyte sedimentation rate; normal levels of the serum tumor markers CEA, CA 19.9 and CA 15.3; squamous carcinoma histology; clinical presentation as lymph node enlargement; and the administration of treatment. Multivariate analysis showed that albumin and alkaline phosphatase levels, squamous carcinoma histology, age and treatment were the most important prognostic factors. Other variables analyzed (liver, bone or lung involvement, lactate dehydrogenase levels, gender) did not affect survival. Conclusions. CUP has a poor prognosis. Some prognostic factors that affect survival in these patients, however, may be identified. Free full text available at www.turnorionline.it
引用
收藏
页码:111 / 116
页数:6
相关论文
共 50 条
  • [41] AKT as Locus of Cancer Unknown Primary Site
    Radisavljevic, Ziv
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2016, 117 (05) : 1066 - 1068
  • [42] Inflammation as a validated prognostic determinant in carcinoma of unknown primary site
    Z Mohamed
    D J Pinato
    F A Mauri
    K-W Chen
    P M-H Chang
    R Sharma
    British Journal of Cancer, 2014, 110 : 208 - 213
  • [43] New Prognostic Index to Predict Survival in Patients with Cancer of Unknown Primary Site with Unfavourable Prognosis
    Trivanovic, D.
    Petkovic, M.
    Stimac, D.
    CLINICAL ONCOLOGY, 2009, 21 (01) : 43 - 48
  • [44] Malignant melanoma of unknown primary site (MUP). Systematic review of the literature with emphasis on survival and prognostic factors
    Kamposioras, K.
    Pentheroudakis, G.
    Pectasides, D.
    Pavlidis, N.
    EJC SUPPLEMENTS, 2009, 7 (02): : 589 - 589
  • [45] Cancer of unknown primary site: Missing primary or missing biology?
    Pentheroudakis, George
    Briasoulis, Evangelos
    Pavlidis, Nicholas
    ONCOLOGIST, 2007, 12 (04): : 418 - 425
  • [46] Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
    Dahl, Mary
    Aurit, Sarah J.
    Silberstein, Peter T.
    Gootee, Jonathan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (10)
  • [47] Cancer of unknown primary site with pathological characteristic of the breast cancer
    Goto, Keiko
    Hashimoto, Jun
    Tanabe, Yuko
    Kodaira, Makoto
    Yamamaoto, Harukaze
    Yunokawa, Mayu
    Yonemori, Kan
    Shimizu, Chikako
    Tamura, Kenji
    Fujiwara, Yasuhiro
    ANNALS OF ONCOLOGY, 2015, 26 : 111 - 112
  • [48] METASTATIC ADENOCARCINOMAS OF UNKNOWN PRIMARY SITE - PROGNOSTIC VARIABLES AND TREATMENT RESULTS
    KAMBHU, SA
    KELSEN, DP
    FIORE, J
    NIEDZWIECKI, D
    CHAPMAN, D
    VINCIGUERRA, V
    ROSENBLUTH, R
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1990, 13 (01): : 55 - 60
  • [49] Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes
    Raghav, Kanwal
    Mhadgut, Hemendra
    McQuade, Jennifer L.
    Lei, Xiudong
    Ross, Alicia
    Matamoros, Aurelio
    Wang, Huamin
    Overman, Michael J.
    Varadhachary, Gauri R.
    PLOS ONE, 2016, 11 (05):
  • [50] Clinical guideline SEOM: cancer of unknown primary site
    R. Collado Martín
    A. García Palomo
    L. de la Cruz Merino
    P. Borrega García
    F. J. Barón Duarte
    Clinical and Translational Oncology, 2014, 16 : 1091 - 1097